Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) and InterCure (NASDAQ:INCR – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.
Risk and Volatility
Green Thumb Industries has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, InterCure has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.
Valuation and Earnings
This table compares Green Thumb Industries and InterCure”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Green Thumb Industries | $1.14 billion | 1.21 | $73.08 million | $0.17 | 39.18 |
| InterCure | $64.55 million | N/A | -$18.32 million | $0.08 | 11.54 |
Green Thumb Industries has higher revenue and earnings than InterCure. InterCure is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and price targets for Green Thumb Industries and InterCure, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Green Thumb Industries | 0 | 1 | 1 | 1 | 3.00 |
| InterCure | 1 | 0 | 0 | 0 | 1.00 |
Institutional and Insider Ownership
0.1% of Green Thumb Industries shares are held by institutional investors. Comparatively, 8.3% of InterCure shares are held by institutional investors. 9.4% of Green Thumb Industries shares are held by company insiders. Comparatively, 0.2% of InterCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Green Thumb Industries and InterCure’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Green Thumb Industries | 3.77% | 1.66% | 1.17% |
| InterCure | N/A | N/A | N/A |
Summary
Green Thumb Industries beats InterCure on 11 of the 13 factors compared between the two stocks.
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.
